Insights

  • Date

  • Content Type

  • Reset

Article

The future of CMC for novel therapies

10.06.22

By Elena Meurer

Novel and advanced therapies have come on in leaps and bounds over the past decade.

Article

Building successful partnerships with scientific due diligence

16.05.22

By Diane Seimetz & Jörg Schneider

How you can ensure a smooth and successful business partnership

Article

The how, why and when of comparability exercises for ATMPs

16.05.22

By Elena Trude

Process changes are an inevitable part of most drug development programs, and this is particularly

Article

Addressing the unique regulatory challenges of gene therapies

11.04.22

By Francesco Lanucara

Gene therapies have the potential to transform the treatment of disease by correcting an underlying

Article

Overcoming challenges for personalized cancer vaccines

11.04.22

By Ilona Baraniak and Aleksandra Nevmerzhitskaya

Advances in the field of personalized cancer vaccines create potential for more targeted, less toxic

Article

Opportunities for Growth and Breakthroughs for Cell and Gene Therapies

6.04.22

By Elena Meurer

A treatment that has been top-of-mind in recent years is cell and gene therapies (CGTs).